Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 430-150-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From August 11 to September 25, 1997
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- GLP study conducted according to OECD test guideline No. 471 and No. 472 with deviation: in the –S9 tests, toxicity was not achieved at the highest concentration. However, in the preliminary test, at 500 µg/plate there were some revertant colonies for 5 out of 6 strains, but in no case there was an increase in revertant count. Therefore, the result is expected to be the same even if a toxic dose level is achieved. A re-test is not required.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 997
- Report date:
- 1997
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- in the –S9 tests, toxicity was not achieved at the highest concentration
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 472 (Genetic Toxicology: Escherichia coli, Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- in the –S9 tests, toxicity was not achieved at the highest concentration
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- yes
- Remarks:
- in the –S9 tests, toxicity was not achieved at the highest concentration
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- [(2S)-3-methoxy-2-methylpropyl]benzene
- Molecular formula:
- C11H16O
- IUPAC Name:
- [(2S)-3-methoxy-2-methylpropyl]benzene
- Reference substance name:
- [(2R)-3-methoxy-2-methylpropyl]benzene
- Molecular formula:
- C11H16O
- IUPAC Name:
- [(2R)-3-methoxy-2-methylpropyl]benzene
- Test material form:
- liquid
- Details on test material:
- - Physical state: Colourless liquid
Constituent 1
Constituent 2
- Specific details on test material used for the study:
- Stored at 4 °C, protected from light and moisture
Method
- Target gene:
- Histidine and tryptophan
Species / strain
- Species / strain / cell type:
- other: S. typhimurium TA1535, TA1537, TA98 and TA100; E. coli WP2(pKM101) and WP2uvrA(pKM101)
- Details on mammalian cell type (if applicable):
- Not applicable
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- 10 % S9; S9-mix from the livers of male Sprague Dawley OFA rats treated with Aroclor 1254 at 500 mg/kg bw.
- Test concentrations with justification for top dose:
- - Preliminary toxicity test: 0, 50, 150, 500, 1500 and 5000 µg/plate in all strains with and without S9-mix using direct plate incorporation method.
- Mutagenicity test (direct plate incorporation method): 0, 1.5, 5, 15, 50 and 150 µg/plate in all strains without S9-mix; 0, 5, 15, 50, 150 and 500 µg/plate in all strains with S9-mix.
- Complementary assay: 0, 5, 50, 150 and 500 µg/plate in TA1537 strain with S9-mix using direct plate incorporation method.
- Mutagenicity test (repeat): 0, 1.5, 5, 15, 50 and 150 µg/plate in all strains without S9-mix using direct plate incorporation method and with S9-mix using pre-incubation method. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: Test material was not soluble in aqueous medium, therefore it was dissolved in DMSO at a concentration of 50 mg/mL. This solution was used at 100 µl/plate giving a final concentration of 5000 µg/plate.
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- mitomycin C
- other: potassium dichromate
- Remarks:
- Without S9-mix
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- other: 2-anthramine
- Remarks:
- With S9-mix
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium; in agar (plate incorporation); preincubation
DURATION
- Exposure duration: Plates were incubated for approximately 48 h at 37 °C.
NUMBER OF REPLICATIONS: Single plate/dose for preliminary toxicity study; triplicate plates per dose level for mutation study.
DETERMINATION OF CYTOTOXICITY
- Method: Microscopic examination of the bacterial background lawn.
OTHER EXAMINATIONS:
- Other: Observations of precipitate of the test substance.
OTHER: READING OF RESULTS:
- After 48 h of incubation at 37 °C, the prototrophic mutant colonies that have developed in the plates are counted using a colony counter.
- The results are expressed as the mean number of revertants per plate and, for each concentration of the test product, the following ratio is established: Mean number of revertants per plate in the presence of the test compound / Mean number of revertants per plate in the solvent control.
OTHER: ACCEPTANCE CRITERIA: The reverse mutation assay was considered valid if the following criteria were met:
- The test compound must be sterile: At the highest dose, after spreading out under the conditions of the toxic activity test and after 48 h incubation at 37 °C, no colony must be visible.
- The mean frequency of spontaneous revertants (solvent control) in each strain must be included between the maximum and minimum historical control values.
- The mean frequency of revertants, for each strain, induced by the reference products both with and without metabolic activation must be greater than the lowest limit historical values. - Rationale for test conditions:
- In the –S9 tests, toxicity was not achieved at the highest concentration. However, in the preliminary test, at 500 µg/plate there were some revertant colonies for 5 out of 6 strains, but in no case there was an increase in revertant count. Therefore, the result is expected to be the same even if a toxic dose level is achieved. A re-test is not required.
- Evaluation criteria:
- - A compound causing a positive response proportional to the dose for at least 3 concentrations with, for the highest increase, a value greater than or equal to 2 times (for strains TA 98, TA 100, WP2(pKM101) and WP2uvrA (pKM101)) or 3 times (for strains TA 1535 and TA 1537) the value for the solvent control, is considered positive in the assay.
- Results were analysed by Dunnett's method when mutant number declined markedly at one or two high doses.
- If a substance produced a positive response during a single assay and that result cannot be reproduced in at least 2 independent assays, the initial positive result may be considered as not significant. - Statistics:
- Results were analysed by Dunnett's method when mutant number declined markedly at one or two high doses.
Results and discussion
Test results
- Key result
- Species / strain:
- other: S. typhimurium TA1535, TA1537, TA98 and TA100; E. coli WP2(pKM101) and WP2uvrA(pKM101)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: Not applicable
- Effects of osmolality: Not applicable
- Evaporation from medium: No data
- Water solubility: Dissolved in DMSO
- Precipitation: None
- Other confounding effects: None
RANGE-FINDING/SCREENING STUDIES: The test item presented withtou metabolic activation a strong toxicity demonstrated by an absence of bacterial growth or by an important decrease in the number of revertants at the three highest doses of 5000, 1500 and 500 µg/plate in the 6 strains tested. Under these conditions, the immediately inferior dose of 150 µg/plate which presented no toxicity, was retained as the high dose for the mutagenicity assay without S9-mix in all bacterial strains.
With S9-mix, at two highest doses of 5000 and 1500 µg/plate, a strong toxicity was observed. The inferior dose of 500 µg/plate which presented a moderate toxicity, was retained as the maximum dose for the mutagenicity assay with S9-mix in all bacterial strains.
However, in the first assay with S9-mix without pre-incubation, a strong or moderate toxicity was noted at the dose of 500 µg/plate in all the strains tested. Consequently, in the second assay, the top dose was reduced to 150 µg/plate.
COMPARISON WITH HISTORICAL CONTROL DATA: The frequency of spontaneous revertants (solvent controls) in each strain was within the limits of historical controls.
Any other information on results incl. tables
None
Applicant's summary and conclusion
- Conclusions:
- Under the test condition, the test material is not mutagenic with and without metabolic activation to S. typhimurium strains TA1535, TA1537, TA98,TA100 and E. coli strains WP2(pKM101) and WP2uvrA(pKM101) according to the criteria of the Annex VI of the of the Regulation (EC) No.1272/2008 (CLP) and according to the GHS.
- Executive summary:
In a reverse gene mutation assay performed according to the OECD test guideline No. 471 and No. 472 and in compliance with GLP, S. typhimurium strains TA1535, TA1537, TA98, TA100 and E. coli strains WP2(pKM101) and WP2uvrA(pKM101) were exposed to the test material diluted in DMSO both in the presence and absence of metabolic activation system using the plate incorporation method. The dose range was determined in a preliminary toxicity assay and ranged between 1.5-150 µg/plate (without S9-mix) and 5- 500 µg/plate (with S9-mix). In a complementary assay with S9-mix in TA1537 strain, dose range was between 5-500 µg/plate. Mutagenicity test was repeated using dose range between 1.5-150 µg/plate in all strains without S9-mix using direct plate incorporation method and with S9-mix using pre-incubation method.
Vehicle (DMSO) and positive control groups were also included in mutagenicity tests.
A significant increase in the number of revertants was observed in the presence of reference positive substances. Thus, the sensitivity of the assay and the efficacy of the S9-mix were validated. The frequency of spontaneous revertants (solvent controls) in each strain was within the limits of historical controls. Toxic effects were noted at 5000, 1500 and 500 µg/plate (without S9-mix) and at 5000 and 1500 µg/plate (with S9-mix) in all the tested strains.
In the absence of metabolic activation, in two independant assays, no significant increase in the number of revertants was noted in the presence of the test compound.
In the first assay in the presence of metabolic activation without pre-incubation, a slight increase (3 times the number of spontaneous revertants) at the limit of biological significance was noted at 50 µg/plate in TA1537 strain. However, in an independent complementary assay performed under the same operating conditions, no significant increase in the number of revertants was observed in this strain. Therefore, the effect observed in the first assay was not reproducible. In addition, it was not dose-related, not statistically significant and cannot be attributed to a significant mutagenic activity of the test compound. Furthermore, in the same first assay with metabolic activation, no significant increase in the number of revertants was seen in other bacterial strains.
In the second assay in the presence of metabolic activation using pre-incubation method, no significant increase in the number of revertants was observed in all the bacterial strains tested.
It is noted that in the first assay in the presence of metabolic activation without pre-incubation in strains TA98 and WP2(pKM101) at the highest dose tested of 500 µg/plate and in the second assay with pre-incubation in all the strains tested at the maximum dose or at two first highest doses of 150 and 50 µg/plate, a statistically significant decrease in the number of revertants was found. However, this effect which was due to the toxic activity of the test compound at high doses, had no meaning in terms of mutagenic hazard.
Under the test condition, the test material is not mutagenic with and without metabolic activation to S. typhimurium strains TA1535, TA1537, TA98,TA100 and E. coli strains WP2(pKM101) and WP2uvrA(pKM101) according to the criteria of the Annex VI of the of the Regulation (EC) No.1272/2008 (CLP) and according to the GHS.
This study is considered as acceptable and satisfies the requirement for reverse gene mutation endpoint.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.